Avacta Group plc (AVCT.L)
Avacta Group plc, a clinical stage biopharmaceutical company, develops cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms in the United Kingdom, North America, South Korea, and rest of Asia and Europe. It operates through Diagnostics and Therapeutics segments. The company develops custom Affimer proteins for customer products and in-house diagnostic assays. It also develops AffiDX SARS-CoV-2 lateral flow rapid antigen tests, as well as Affimer reagents for third party products; and novel cancer immunotherapies combining proprietary platforms. The company has a research collaboration with pre|CISION technology incorporates a substrate that is sensitive to cleavage by fibroblast activation protein alpha; drug development collaboration with LG Chem Life Sciences; partnership with Tufts University School of Medicine for developing Affimer drug conjugate therapies; licensing agreement with POINT Biopharma Inc. for the development of tumour activated radiopharmaceuticals; and drug development partnership with AffyXell to develop engineered mesenchymal stem cells to treat autoimmune diseases. Avacta Group plc was incorporated in 2003 and is based in Wetherby, the United Kingdom.
Company Info
Highlights
£171.78M
-£0.09
£11.26M
£3.05M
-£4.51M
£39.50 - £95.00
£106.00
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of £10,000 in Avacta Group plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Avacta Group plc had a return of -10.00% year-to-date (YTD) and -52.13% in the last 12 months. Over the past 10 years, Avacta Group plc had an annualized return of -6.53%, while the S&P 500 had an annualized return of 11.33%, indicating that Avacta Group plc did not perform as well as the benchmark.
AVCT.L
-10.00%
-15.09%
-36.17%
-52.13%
8.64%
-6.53%
^GSPC (Benchmark)
3.96%
1.97%
10.09%
22.16%
12.70%
11.33%
Monthly Returns
The table below presents the monthly returns of AVCT.L, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -5.00% | -10.00% | |||||||||||
| 2024 | -11.16% | -47.34% | -8.72% | -8.04% | -11.69% | 37.38% | 22.52% | 5.15% | -31.47% | 2.04% | -3.60% | 3.73% | -57.08% |
| 2023 | 24.09% | 0.21% | -22.38% | 10.81% | -12.20% | -0.46% | -12.56% | 12.77% | 15.57% | 10.61% | 1.11% | -14.96% | 1.30% |
| 2022 | -32.38% | -40.73% | 46.53% | 65.00% | -0.74% | -10.48% | 1.38% | 14.18% | -15.45% | 18.68% | -19.05% | 12.75% | -8.70% |
| 2021 | 7.89% | 58.54% | 12.82% | 20.91% | -10.90% | -25.49% | -22.99% | -4.41% | -10.00% | 0.00% | -1.03% | 8.81% | 10.53% |
| 2020 | 31.88% | 0.00% | -4.40% | 339.08% | 90.05% | -40.50% | 38.89% | 10.33% | -6.34% | 4.84% | -24.92% | -6.56% | 560.87% |
| 2019 | 39.34% | -4.00% | -12.99% | -10.56% | -6.30% | -0.84% | -10.17% | -20.75% | -3.57% | -20.99% | 6.25% | 1.47% | -43.44% |
| 2018 | 1.56% | -18.46% | -33.02% | -14.08% | 11.48% | -14.71% | -14.83% | 11.34% | -9.09% | -3.60% | -6.22% | 34.96% | -52.34% |
| 2017 | -2.78% | -5.00% | -8.27% | 46.72% | 7.82% | -9.84% | -6.90% | -8.02% | -8.05% | -2.92% | -1.50% | -2.29% | -11.11% |
| 2016 | -8.92% | -2.86% | -3.36% | -2.17% | -4.00% | -15.74% | -7.14% | 17.16% | -3.79% | -6.04% | -10.61% | -10.00% | -46.47% |
| 2015 | 11.72% | 19.58% | 1.17% | -2.31% | 33.14% | 11.56% | 13.55% | -10.18% | 8.98% | -3.58% | -0.00% | 0.00% | 110.16% |
| 2014 | 1.34% | 3.08% | -1.28% | -2.60% | 0.44% | 0.44% | -7.49% | -20.95% | -3.61% | -4.37% | -17.65% | 1.59% | -42.86% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of AVCT.L is 13, meaning it’s performing worse than 87% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Avacta Group plc (AVCT.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Avacta Group plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Avacta Group plc was 99.66%, occurring on Mar 18, 2020. The portfolio has not yet recovered.
The current Avacta Group plc drawdown is 98.90%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.66% | Aug 27, 2004 | 3273 | Mar 18, 2020 | — | — | — |
Volatility
Volatility Chart
The current Avacta Group plc volatility is 12.57%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Avacta Group plc.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |